목차
COUGH AND HEMOPTYSIS -- EUGENE BRAUNWALD*
COUGH
HEMOPTYSIS
REFERENCES
COUGH
HEMOPTYSIS
REFERENCES
본문내용
dropouts attributable to adverse experiences were significantly less (p less than 0.05) in the iodinated glycerol group.(ABSTRACT TRUNCATED AT 250 WORDS)
Comment(s):
in Chest 1990 Nov;98(5):1309-10
Address: University of Colorado Health Sciences Center, Denver.
UI: 90107584
Title: Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol
Journal: Chest 95:723-728, 1989
Publication Date: 1989 Apr
Author(s): Poe RH, Harder RV, Israel RH, Kallay MC
Abstract: Irwin and co-workers have designed an anatomic approach to the diagnosis and treatment of cough. In their hands, diagnosis was consistently determined and treatment successful almost without exception, if sustained. We reviewed the results of a similar approach in 139 consecutive and unselected patients referred to pulmonary specialists in two community hospitals. Thirty-nine patients demonstrated hyperreactive airways (HA) by carbachol inhalation and/or eucapnic hyperventilation of cold air. Twenty-seven of 78 without HA had postnasal drip, and 13 of 78 had a persistent cough following acute upper airway inflammation. Other less common diagnoses included chronic bronchitis, gastro-esophageal reflux, occupational bronchitis, interstitial lung disease, and psychologic causes. We were able to find the cause of cough 88 percent of the time. Treatment adjusted for noncompliance was not always a success. While all patients with HA improved, 8 percent of patients without HA or specific diagnosis did not have an improvement in their cough upon retrospective inquiry. Based on this analysis, we find that the diagnosis and treatment of cough may not be as successful as originally reported using Irwin's approach.
Address: Department of Medicine, Highland Hospitals, Rochester, New York 14620.
UI: 89169709
Title: Embolotherapy for persistent hemoptysis: the significance of pleural thickening
Journal: Cardiovasc Intervent Radiol 16:85-88, 1993
Publication Date: 1993 Mar-Apr
Author(s): Tamura S, Kodama T, Otsuka N, Kihara Y, Nisikawa K, Yuki Y, Samejima M, Uwada O, Watanabe K, Minoda S
Abstract: Elective embolotherapy for recurrent hemoptysis was evaluated for its effectiveness. Forty embolotherapeutic procedures were performed in 30 patients. In the short term, complete hemostasis was achieved in 16 of 40 procedures (40%) and significant improvement in another 16 procedures (40%). Long-term, complete hemostasis was achieved in 14 of 34 procedures (41%) and significant improvement in 12 (35%). Embolotherapy was consistently more effective in patients who had no pleural abnormalities compared with those with pleural thickening. Long-term complete hemostasis was achieved in 7 of 10 procedures (70%) for the patients without pleural thickening and only 7 of 24 (29%) in patients with pleural thickening. Thus, pleural abnormalities negatively influence long-term effectiveness of embolotherapy.
Address: Department of Radiology, Miyazaki Medical College, Japan.
UI: 93251498
Comment(s):
in Chest 1990 Nov;98(5):1309-10
Address: University of Colorado Health Sciences Center, Denver.
UI: 90107584
Title: Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol
Journal: Chest 95:723-728, 1989
Publication Date: 1989 Apr
Author(s): Poe RH, Harder RV, Israel RH, Kallay MC
Abstract: Irwin and co-workers have designed an anatomic approach to the diagnosis and treatment of cough. In their hands, diagnosis was consistently determined and treatment successful almost without exception, if sustained. We reviewed the results of a similar approach in 139 consecutive and unselected patients referred to pulmonary specialists in two community hospitals. Thirty-nine patients demonstrated hyperreactive airways (HA) by carbachol inhalation and/or eucapnic hyperventilation of cold air. Twenty-seven of 78 without HA had postnasal drip, and 13 of 78 had a persistent cough following acute upper airway inflammation. Other less common diagnoses included chronic bronchitis, gastro-esophageal reflux, occupational bronchitis, interstitial lung disease, and psychologic causes. We were able to find the cause of cough 88 percent of the time. Treatment adjusted for noncompliance was not always a success. While all patients with HA improved, 8 percent of patients without HA or specific diagnosis did not have an improvement in their cough upon retrospective inquiry. Based on this analysis, we find that the diagnosis and treatment of cough may not be as successful as originally reported using Irwin's approach.
Address: Department of Medicine, Highland Hospitals, Rochester, New York 14620.
UI: 89169709
Title: Embolotherapy for persistent hemoptysis: the significance of pleural thickening
Journal: Cardiovasc Intervent Radiol 16:85-88, 1993
Publication Date: 1993 Mar-Apr
Author(s): Tamura S, Kodama T, Otsuka N, Kihara Y, Nisikawa K, Yuki Y, Samejima M, Uwada O, Watanabe K, Minoda S
Abstract: Elective embolotherapy for recurrent hemoptysis was evaluated for its effectiveness. Forty embolotherapeutic procedures were performed in 30 patients. In the short term, complete hemostasis was achieved in 16 of 40 procedures (40%) and significant improvement in another 16 procedures (40%). Long-term, complete hemostasis was achieved in 14 of 34 procedures (41%) and significant improvement in 12 (35%). Embolotherapy was consistently more effective in patients who had no pleural abnormalities compared with those with pleural thickening. Long-term complete hemostasis was achieved in 7 of 10 procedures (70%) for the patients without pleural thickening and only 7 of 24 (29%) in patients with pleural thickening. Thus, pleural abnormalities negatively influence long-term effectiveness of embolotherapy.
Address: Department of Radiology, Miyazaki Medical College, Japan.
UI: 93251498